TOPLINE: Long-term gender-affirming hormone treatment with testosterone increases the risk for metabolic syndromes in transmasculine individuals, whereas transfeminine individuals receiving estradiol have a lower risk. METHODOLOGY: […]

TOPLINE: More than a third of substance-use treatment facilities do not offer medications for opioid use disorder (MOUD), and less than half were offered evidence-based psychosocial […]

TOPLINE: For patients with head and neck squamous cell carcinoma, utilizing fluorodeoxyglucose-(FDG)-PET/CT imaging to assess their response to chemoradiation significantly increases the accuracy in identifying which […]

TOPLINE: A high-fiber diet affects small intestine metabolism, spurring release of the appetite-suppressing gut hormone peptide tyrosine tyrosine (PYY) more than a low-fiber diet, and it […]

TOPLINE: A perioperative enhanced recovery protocol significantly improved the postoperative outcomes in patients undergoing ileocecal resection for Crohn’s disease, speeding discharge readiness and reducing complications and […]

TOPLINE: The use of menopausal hormone therapy (MHT) increases breast cancer risk in women with a strong family history of breast cancer. These women have a […]

TOPLINE: In spontaneously pregnant women with initial thyroid-stimulating hormone (TSH) < 2.5 mU/L and thyroid autoimmunity, biochemical progression of serum TSH > 2.5 mU/L was infrequent […]

TOPLINE: Reducing screen time for entire families — parents, children, and adolescents — over a 2-week period can improve the mental health of children and adolescents, […]

TOPLINE: Surveillance of high-risk individuals may detect pancreatic ductal adenocarcinoma at an earlier stage, when the tumor is smaller and easier to treat, and could help […]